RAP 0.00% 20.5¢ resapp health limited

Ann: Positive Results from Australian Adult Clinical Studies, page-46

  1. 1,558 Posts.
    lightbulb Created with Sketch. 28
    Why did you only focus on asthma? Did you check on pneumonia numbers? I also think you're making some dodgy assumptions of RAP's pricing model. I'd imagine it would more be a license charge where its $x amount per diagnosis rather than a flat fee of $20 for the app.
    Last edited by Keffola: 18/12/17
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.